AI-generated summary
The authors report a pilot study of 20 adults with COVID-19-related anosmia and ageusia who received intranasal and intraoral photobiomodulation. Smell and taste were rated by patients on a visual analogue scale, and the authors report a significant improvement in both. They note that larger studies with long-term follow-up are needed.
- Participants
- 20
- Who or what was studied
- Twenty Caucasian adults diagnosed with anosmia and ageusia after COVID-19
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The study is a small pilot with self-reported outcomes and no control group, and the abstract states that larger studies with longer follow-up are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 808 nm
- Power
- 100 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Visual analogue scale, Pilot study, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.